Compounds > dexmedetomidine
Page last updated: 2024-08-24

dexmedetomidine and Metastase

dexmedetomidine has been researched along with Metastase in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Chen, P; Dai, G; Hong, J; Jiang, Y; Li, A; Lin, W; Luo, X; Luo, Y; Ning, X; Peng, S; Qu, C; Wang, H; Xie, P1
Bai, Y; He, H; Huang, L; Liu, W; Zhang, P1
Ben-Eliyahu, S; Benbenishty, A; Cata, JP; Elbaz, E; Gottumukkala, V; Haldar, R; Lavon, H; Matzner, P; Rossene, E; Sorski, L1
Fan, Y; Fang, Y; Huang, J; Qiao, F; Su, X; Wang, J; Yang, L1
Chen, Y; Deng, F; Ouyang, M; Sun, X; Tang, J; Tao, T; Wang, X; Xu, L; Yao, X; Zhao, L1

Other Studies

5 other study(ies) available for dexmedetomidine and Metastase

ArticleYear
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.
    Experimental & molecular medicine, 2020, Volume: 52, Issue:7

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chemokines; Dexmedetomidine; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Humans; Interleukin-6; Liver Cirrhosis; Liver Neoplasms; Male; Mice, Inbred C57BL; Neoplasm Metastasis; Receptors, Adrenergic, alpha-2; STAT3 Transcription Factor

2020
Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis.
    Anti-cancer drugs, 2020, Volume: 31, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Analgesics, Non-Narcotic; Animals; Antineoplastic Agents; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Dexmedetomidine; Disease Progression; Down-Regulation; Esophageal Neoplasms; Humans; Mice; MicroRNAs; Neoplasm Metastasis; Signal Transduction; Xenograft Model Antitumor Assays

2020
Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers.
    British journal of anaesthesia, 2018, Volume: 120, Issue:1

    Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Carcinoma, Lewis Lung; Colonic Neoplasms; Dexmedetomidine; Female; Hypnotics and Sedatives; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-2

2018
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery.
    Journal of translational medicine, 2018, 12-11, Volume: 16, Issue:1

    Topics: Aged; Animals; Cell Line, Tumor; Cell Proliferation; Dexmedetomidine; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Mice, Inbred C57BL; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Neoplasm Metastasis; Neovascularization, Pathologic; Receptors, Adrenergic, alpha-2; Vascular Endothelial Growth Factor A

2018
Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application.
    Oncotarget, 2016, Nov-22, Volume: 7, Issue:47

    Topics: Anesthetics, Intravenous; Animals; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Dexmedetomidine; Disease Progression; Epithelial-Mesenchymal Transition; Etomidate; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Prognosis; Propofol; Proto-Oncogene Proteins c-akt; Signal Transduction

2016